[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100552247":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":15,"responsibleParty":30,"collaborators":7,"id":34,"slug":7,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":38,"acronym":39,"eligibilityCriteria":40,"healthyVolunteers":35,"sex":41,"minAge":42,"maxAge":7,"enrollmentInfo":43,"targetDuration":7,"studyType":46,"phases":7,"briefSummary":47,"conditions":48,"keywords":51,"overallStatus":18,"whyStopped":7,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"Scientific Institute San Raffaele","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":13,"email":14},"Pierluigi Novellis, MD","CONTACT","+39022643","7202","novellis.pierluigi@hsr.it",[16],{"facility":17,"status":18,"city":19,"state":7,"zip":20,"country":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"Scientific Institute Ospedale San Raffaele","RECRUITING","Milan","20132","Italy",{"type":23,"coordinates":24},"Point",[25,26],9.18951,45.46427,{"lat":26,"lon":25},[29],{"name":10,"role":11,"phone":12,"phoneExt":13,"email":7},{"type":31,"investigatorFullName":32,"investigatorTitle":33,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Pierluigi Novellis","MD","100552247",false,"NCT06470607","The Lymphocytic Infiltrate of Lung Tumors.","Biological Observational Monocentric Study Aimed at Analyzing the Lymphocytic Infiltrate of Lung Tumors","TREGILC","Inclusion Criteria:\n\n* Ability to provide informed consent;\n* Men and women over the age of 18;\n* Patients candidates for surgical treatment diagnosed with thoracic tumors\n\nExclusion Criteria:\n\n* Previous chemotherapy for any cancer within the last 6 months;\n* Pregnant and\u002For breastfeeding women;\n* Immunosuppressive state (states of immunosuppression or ongoing immunosuppressive\u002Fimmunomodulatory treatments)","ALL","18 Years",{"count":44,"type":45},70,"ESTIMATED","OBSERVATIONAL","The study is configured as a monocentric observational transversal biological study.\n\nThe main objective of the study is the reconstruction of the molecular organization of tumors of the thoracic cavity, in particular non-small cell lung cancer (NSCLC).\n\nThe study involves the collection of clinical data and biological material (blood and tumor tissue) from 70 subjects diagnosed with thoracic tumors.",[49,50],"Lung Cancer","Immune System",[52,53,54],"thoracic tumors","Immune checkpoints","lymphocytes","2024-11-26",{"date":57,"type":58},"2024-11-29","ACTUAL",{"date":60,"type":58},"2023-01-20",{"date":62,"type":45},"2028-01-31",{"name":5,"class":6},1]